The Market Is Wrong About Vertex
Motley Fool
Vertex falls after analyst expresses doubt about cystic fibrosis drug
The Fly on the Wall
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Vertex shares soar on cystic fibrosis study
Markewatch
Biotech Takeovers: Who's Next On The Block?
Seeking Alpha
Valeant: Why Investors Are Getting In Now
Seeking Alpha
Investors Actively Trade These 4 Healthcare Stocks Post Earnings
Wall St. Cheat Sheet
Celebrate the Hep C Wins, for Now
Motley Fool